MBX-2044: Phase IIa started

By WIR Staff | Jan 1, 2007 | 8:00 AM GMT

Metabolex began a double-blind, placebo-controlled Phase IIa trial

Read the full 89 word article

How to gain access

Continue reading with a
two-week free trial.